Develops research, programs, and initiatives designed to envision and activate sustainable solutions leading to better health for individuals and communities worldwide.
This report uses the 2022 Global Opportunity Index (GOI) and its various categories to examine the
attractiveness of emerging Southeast Asia as a foreign investment destination—especially when compared to other emerging markets and developing economies
In partnership with the US Department of Health and Human Services (HHS) Accelerate Clinical Innova
tion Initiative, the Milken Institute has identified health innovation gaps as well as disease and condition categories with the highest economic and soci